Cartesian Therapeutics
RNAC
#6809
Rank
ยฃ0.38 B
Marketcap
ยฃ15.11
Share price
-1.30%
Change (1 day)
-10.41%
Change (1 year)

Revenue for Cartesian Therapeutics (RNAC)

Revenue in 2024 (TTM): ยฃ37.83 Million

According to Cartesian Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ38.08 Million. In 2023 the company made a revenue of ยฃ20.41 Million a decrease over the revenue in the year 2022 that were of ยฃ91.56 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cartesian Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ37.83 M85.37%
2023 ยฃ20.41 M-77.71%
2022 ยฃ91.56 M45.28%
2021 ยฃ63.02 M417.63%
2020 ยฃ12.17 M139.13%
2019 ยฃ5.09 M615.77%
2018 ยฃ0.71 M364.46%
2017 ยฃ0.15 M-97.66%
2016 ยฃ6.55 M61.5%
2015 ยฃ4.05 M